F-18-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors

作者：Toyonaga Takuya; Hirata Kenji; Yamaguchi Shigeru^*; Hatanaka Kanako C; Yuzawa Sayaka; Manabe Osamu; Kobayashi Kentaro; Watanabe Shiro; Shiga Tohru; Terasaka Shunsuke; Kobayashi Hiroyuki; Kuge Yuji; Tamaki Nagara

来源：European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43(8): 1469-1476.

DOI：10.1007/s00259-016-3320-x

• Necrosis
• FMISO PET
• Hypoxia
• Brain tumor
• Biopsy
• Histology

Tumor necrosis is one of the indicators of tumor aggressiveness. F-18-fluoromisonidazole (FMISO) is the most widely used positron emission tomography (PET) tracer to evaluate severe hypoxia in vivo. Because severe hypoxia causes necrosis, we hypothesized that intratumoral necrosis can be detected by FMISO PET in brain tumors regardless of their histopathology. We applied FMISO PET to various types of brain tumors before tumor resection and evaluated the correlation between histopathological necrosis and FMISO uptake.
This study included 59 brain tumor patients who underwent FMISO PET/computed tomography before any treatments. According to the pathological diagnosis, the brain tumors were divided into three groups: astrocytomas (group 1), neuroepithelial tumors except for astrocytomas (group 2), and others (group 3). Two experienced neuropathologists evaluated the presence of necrosis in consensus. FMISO uptake in the tumor was evaluated visually and semi-quantitatively using the tumor-to-normal cerebellum ratio (TNR).
In visual analyses, 26/27 cases in the FMISO-positive group presented with necrosis, whereas 28/32 cases in the FMISO-negative group did not show necrosis. Mean TNRs with and without necrosis were 3.49 +/- 0.97 and 1.43 +/- 0.42 (p < 0.00001) in group 1, 2.91 +/- 0.83 and 1.44 +/- 0.20 (p < 0.005) in group 2, and 2.63 +/- 1.16 and 1.35 +/- 0.23 (p < 0.05) in group 3, respectively. Using a cut-off value of TNR = 1.67, which was calculated by normal reference regions of interest, we could predict necrosis with sensitivity, specificity, and accuracy of 96.7, 93.1, and 94.9 %, respectively.
FMISO uptake within the lesion indicated the presence of histological micro-necrosis. When we used a TNR of 1.67 as the cut-off value, intratumoral micro-necrosis was sufficiently predictable. Because the presence of necrosis implies a poor prognosis, our results suggest that FMISO PET could provide important information for treatment decisions or surgical strategies of any type of brain tumor.

• 出版日期2016-7